A review of the association between baseline [ 18 F] fluorodeoxyglucose uptake and axillary pathological complete response in node-positive breast cancer patients: focus on clinical subtypes.

In patients with ER+/HER2− breast tumors, the mean baseline axillary SUVmax [median (range)] was slightly higher in patients with axillary pCR [5.4 (1.5–11.3)] compared with patients with axillary residual disease [4.7 (1.2–10.2)], although this difference did not reach statistical significance ( P = 0.887) (Table 3 ) [ 14 ].

also in 111,027 other papers